Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.

Severe infection with Covid-19 has been found to produce a powerful cancer-fighting cell that can shrink tumors.

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

T cell-based immunotherapies including immune checkpoint blockade and chimeric antigen receptor T cells can induce durable responses in patients with cancer. However, clinical efficacy is limited due ...

Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...

Application error: a client-side exception has occurred (see the browser console for more information).

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

“We connect NK cells with tumor cells so they can destroy ... Innate Pharma’s therapies mark the dawn of a new generation of immunotherapy agents. “For the last 10 years, I think ...

For solid tumors and hematological malignancies, CAR-NK cell treatment is a novel kind of cancer immunotherapy. CAR-NK cells work by killing cancer cells in a CAR-dependent way. CAR-NK cells and ...